Interview with John Norman, Country Manager, Nycomed South Africa
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
Address: 65 Peter Place
Bryanston Extension 13
2021 Republic of South Africa
Tel: +27 11 840 2300
Web: http://www.alcon.com/en/alcon-locations/africa.aspx
Founded in 1945, Alcon traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.
The strengths of Alcon, CIBA VISION and Novartis Ophthalmics unite into one eye care business with Alcon becoming the second largest division of Novartis. With these collective resources and scale, Alcon offers the widest spectrum of eye care products in Surgical, Pharmaceutical and Vision Care across 180 markets and runs operations in 75 countries.
Incorporated in 1977, Alcon South Africa employs nearly 90 people focused on serving the needs of health care professionals in the area.
Alcon develops, manufactures and markets surgical equipment and devices, pharmaceuticals and vision care products in more than 180 countries. At the heart of Alcon’s ability to deliver ‘best in class’ products year after year is our Research & Development organization. All of our many engineers, scientists and medical professionals are dedicated to meeting the world’s eye health needs. In 2010, we invested USD 747 million in the pursuit of new products to enhance, preserve and restore vision. Over the next five years, Alcon plans to invest approximately USD 4 billion to discover and develop new treatment solutions for vision conditions and eye diseases.
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
See our Cookie Privacy Policy Here
